Clinical Trials Matching Software Market Worth $396.1 Million By 2030
Clinical Trials Matching Software Industry Overview The global clinical trials matching software market size was valued at USD 132.8 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.8% from 2022 to 2030. Pharmaceutical manufacturers, biotechnology companies, clinical research organizations (CROs), and medical device manufacturers frequently conduct clinical trials to test the safety and efficacy of novel medications, diagnostics, and therapies. The rising prevalence of chronic diseases and the growing need for clinical trials are expected to contribute to the market growth. Clinical trials are increasingly conducted in developing regions as the availability for patient recruitment and matching is a crucial part of clinical trials. Gather more insights about the market drivers, restrains and growth of the Global Clinical Trials Matching Software Market The COVID-19 pandemic had a significant impact, particularly on the hospitals, due to t...